Smith & Nephew plc ADR(SNN) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 4:00 PM ET (Korea 9/12 05:00)
Full metrics table
| Index | - | P/E | 18.75 | EPS (ttm) | 1.47 | Insider Own | 0.06% | Shs Outstand | 424.7M | Perf Week | -4.15% |
| Market Cap | 11.51B | Forward P/E | 11.45 | EPS next Y | 9.06% | Insider Trans | - | Shs Float | 418.3M | Perf Month | -7.84% |
| Enterprise Value | 14.56B | PEG | 1.19 | EPS next Q | 0.53 | Inst Own | 13.55% | Short Float | 1.49% | Perf Quarter | -10.34% |
| Income | 0.63B | P/S | 1.83 | EPS this Y | 7.92% | Inst Trans | -2.65% | Short Ratio | 3.7 | Perf Half Y | -16.77% |
| Sales | 6.29B | P/B | 2.24 | EPS next 5Y | 9.6% | ROA | 5.82% | Short Interest | 6.24M | Perf YTD | -16.18% |
| Book/sh | 12.26 | P/C | 15.18 | EPS past 3/5Y | 41.4% 6.97% | ROE | 11.8% | 52W High | -28.74% ($38.59) | Perf Year | -28.63% |
| Cash/sh | 1.81 | P/FCF | 13.55 | Sales past 3/5Y | 5.84% 6.1% | ROIC | 7.51% | 52W Low | -0.2% ($27.56) | Perf 3Y | 2.65% |
| Dividend Est. | $0.79 (2.87%) | EV/EBITDA | 8.71 | EPS Y/Y TTM | 31.02% | Gross Margin | 68.21% | Volatility(W/M) | 2.53% 1.73% | Perf 5Y | -25.94% |
| Dividend TTM | 0.78 | EV/Sales | 2.32 | Sales Y/Y TTM | 5.26% | Oper. Margin | 17.05% | ATR (14) | 0.64 | Perf 10Y | -15.33% |
| Dividend Ex-Date | 2026/10/2 | Quick Ratio | 1.11 | EPS Q/Q | 4.72% | Profit Margin | 10.08% | RSI (14) | 30.82 | Recom | 3 |
| Dividend Gr. 3/5Y | 0.91% 0.54% | Current Ratio | 2.14 | Sales Q/Q | 3.61% | SMA20 | -4.89% ($28.91) | Beta | 0.56 | Target Price | $31.81 |
| Payout | 52.04% | Debt/Eq | 0.73 | Earnings | 2026/8/4 | SMA50 | -8.21% ($29.96) | Rel Volume | 0.68 | Prev Close | $27.62 |
| Employees | 18362 | LT Debt/Eq | 0.62 | EPS/Sales Surpr. | 0.72% -10.44% | SMA200 | -13.85% ($31.92) | Avg Volume(3M) | 1.69M | Price | $27.5 |
| IPO | 1999/11/16 | Option/Short | Yes/Yes | Trades | 7212 | Volume | 1,140,432 | Change | -0.43% |
Company
SNN is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
A global medical device company headquartered in the UK, specializing in orthopedic implants such as artificial joints, sports medicine devices, and wound care products, listed on the US market in ADR form.
Over the past 1 year, on the lower side
29% below its 1-year high.
Upcoming eventsNext ex-dividend (upcoming)
Ex-dividend October 2
SNN makes money exceptionally well
17.05% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +7.9% this year.
Tap to view numbers
The stock looks undervalued
Trading at 18.8 times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Would have changed by +2.6% if bought 5 years ago.
Tap to view numbers
Dividends are paid consistently
Pays 2.87% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 13.6%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
MDEV 0.02%
PIEQ 0.02%
BINV 0.02%
SAGP 0.01%
TIIV 0.01%It ranks #4 in the industry
Based on market cap of $12B.
SNN $12B PER 18.8
ABT $176B PER 33.0
MDT $116B PER 22.4
SYK $106B PER 28.6
FAQ
What kind of company is SNN?
SNN belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of SNN?
The market cap of SNN is approximately $11.5B, ranking 868 within its sector.
Does SNN pay dividends?
SNN has a dividend yield of approximately 2.87%, with an annual dividend of $0.79.
What is the P/E ratio of SNN?
SNN has a P/E ratio of approximately 18.8x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for SNN?
SNN has recorded a 52-week high of $38.59 and a low of $27.56.
